Ansøgningen om ændring under proceduren for gensidig anerkendelse DE/ H/ 158/ 01/ II/ 32 vedrørte en udvidelse af indikationen til at omfatte let til moderat PID (pelvic inflammatory disease), dvs. infektioner i de øvre genitaler, herunder salpingitis og endometritis.
The MRP variation application DE/ H/ 158/ 01/ II/ 32 concerned an extension of the indication to include the treatment of mild to moderate pelvic inflammatory disease (PID), i. e. infections of upper genital tract, including salpingitis and endometritis.